MARKETWIRE.NET

Decode Your Next Market Move

Global Industry Analysts, Inc. (GIA) launches comprehensive analysis of industry segments, market trends, growth drivers, market share, size and demand forecasts on the global Gene Amplification Technologies market. Market segmentation includes Applications (Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety, and Other Applications).

Find Out More About Regions, Brands, Dominant, Active & Niche Companies Covered in the Report

24 November 1:15 a.m., Silicon Valley, California - According to the new market research report, the global market for Gene Amplification Technologies is projected to grow at a CAGR of 11.4% reach US$6.9 billion by 2027, driven by the increase in demand for the collection of genetic data for identification as well as mapping of all human genome genes. Gene amplification technology remains a major technology and finds use in genomic projects, and applications like diagnostics. There are a lot of gene- as well as signal-amplification technologies ranging from polymerase to ligase chain reaction, dendritic polymers, and transcription-mediated amplification. Such technologies find wide use in several applications in clinical and research settings. Other factors that are shaping the growth of the market for gene amplification technologies are increased focus on drug discovery, R&D in the molecular diagnostic field, toxicology, genetic testing, animal husbandry, environmental monitoring, quality assurance in the industry for food products, forensics, and bioremediation.

There is an increasing focus on developing genomic databases that have led to major changes in the systems of healthcare by hastening the progress for research in personalized medicines, drug development, gene therapies, and clinical research. Additionally, the progress in genomic applications creates profitable possibilities for vendors offering reagents and specialized kits exclusively allocated for particular research applications. Thus, the rise in genomic research in the healthcare industry is likely to fuel market growth during the forecast period. However, due to the high cost involved in the development of gene amplification technologies, the market growth of such technology is hindered to a certain extent.

Gene amplification technology remains a major technology and finds use in genomic projects, and applications like diagnostics. There are a lot of gene- as well as signal-amplification technologies ranging from polymerase to ligase chain reaction, dendritic polymers, and transcription-mediated amplification. Such technologies find wide use in several applications in clinical and research settings. There is an increase in demand for gene amplification kits as well as the assessment of genomic research. There is an increasing focus on developing genomic databases that have led to major changes in the systems of healthcare by hastening the progress for research in personalized medicines, drug development, gene therapies, and clinical research. Additionally, the progress in genomic applications creates profitable possibilities for vendors offering reagents and specialized kits exclusively allocated for particular research applications. Thus, the rise in genomic research in the healthcare industry is likely to fuel market growth during the forecast period.

Research Methodology
This latest edition of the research study is conducted and published by Global Industry Analysts, Inc., in close collaboration with senior executives in the industry driving strategy, business development, marketing, sales, product management, technology and operations. All analysis and findings published in the report are based on validated engagements from a total executive pool size of 4227. Among this pool, 761 direct interactions with domain experts were carried out via our proprietary market research platform, MarketGlass. Among the 127 unique participations, a total of 57 validated responses were received as part of this report's primary research outreach program.

Key Competitors Covered in the Report -
Agilent Technologies, Inc.
Becton, Dickinson and Company
PerkinElmer, Inc.
Bio-Rad Laboratories, Inc.
GE Healthcare
bioMerieux SA
Promega Corporation
Abbott Molecular, Inc.
Charles River Laboratories International, Inc.
Cepheid
Eppendorf AG
F. Hoffmann-La Roche AG

Segments Covered in the Report -
Application (Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety, Other Applications)

Geographies Analyzed in the Report -
World
USA
Canada
Japan
China
Europe
France
Germany
Italy
UK
Rest of Europe
Asia-Pacific
Rest of World.

View Executive Engagement Dashboards, COVID Impact Questionnaires & Get Complimentary Access to Methodology & Full-Text Secondary Sources

For enquiries e-mail us at sales@strategyR.com .

For cutting edge analyst reviews on top industries, follow us on Twitter and connect with us on LinkedIn

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) (www.strategyr.com) is the world`s only influencer driven AI powered market research company. Serving more than 41,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for 33 years, offering the widest coverage of topics, geographic markets, competitive brands, and companies profiled.

Contact Us:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
Email: sales@StrategyR.com